Recent studies have affirmed SSP’s efficacy in encouraging and facilitating entry into treatment for intravenous drug users (IDUs) and thereby reducing illicit drug use. Numerous studies have also documented SSP’s effectiveness in reducing the risk of HIV infection among IDUs and their partners. A summary of these studies is available below.
Federal Register Notice: Determination that a Demonstration Needle Exchange Program Would be Effective in Reducing Drug Abuse and the Risk of Acquired Immune Deficiency Syndrome Infection Among Intravenous Drug Users
Last Updated 2/24/2011